BEAUTY

I Stopped My Lash Serum at Week 16 Over One Side Effect

I ran a 16-week lash test between May and September. Prescription bimatoprost cost $125 a bottle. The peptide serum from Ulta cost $28. My lashes measured 3 millimeters longer at the peak. I quit both at week 16 over iris darkening risk. Growth like that was not worth one warning.

Tessa Whitcomb
Staff Writer
September 14, 2026 · 4 min read

Sixteen weeks, and I was holding a single shed lash against a white index card at 9:10 on a Tuesday night. The card had been taped to my bathroom mirror since May 18, with pencil marks at 6, 8, and 10 millimeters. Under the magnifying mirror, one lash from the sink edge, tweezers in my other hand, laid against the paper. Eight and a half millimeters. Close to the 9 mark, and I already knew that was as far as this experiment was ever gonna go.

The money side ran like this. Bimatoprost, the prescription stuff, cost $125 a bottle through a telehealth dermatology service after a $39 video consult with Dr. Ellis Tran. The peptide serum from the endcap at Ulta cost $28 on sale, normally $38. Two bottles, four months, about $230 spent on eyelashes. The other stake had no price on it. In the bimatoprost packet, one warning got its own paragraph: iris darkening, possibly permanent, reported most in patients using the drops for glaucoma.

I quit at the peak. Week 16, longest lashes of my adult life, and I put both bottles in the drawer on purpose, with the lashes still improving. The index card explains the decision better than any ad could, millimeter by millimeter, and it is still taped to the mirror.

week zero, two index cards

I began with two cards, one taped by the mirror and one in my desk drawer as a backup, plus phone photos under natural window light. Baseline measured 6 millimeters on the longest upper lashes of both eyes. Dr. Tran walked me through the mechanism on the consult: bimatoprost keeps follicles in the growth phase longer, so lashes grow longer before they shed, and the same drug in eye-drop form treats glaucoma. He prescribed it in four minutes. The packet insert took me forty minutes to actually read.

$125 against $28

The prescription ran May 18 thru mid-July, one bottle, applied nightly with a thin brush along the upper lash line. It worked. The first two weeks came with mild itching along the lids, then nothin'. When the bottle emptied, the refill quote came back at $125 again, and the peptide serum, the $28 Ulta one with a peptide base and no prostaglandin analogs on the label, went into rotation for the back half of the test. I measured on the same card, same tweezers, same Tuesday check-ins.

week six, the first mark

Week 6 was the first pencil mark past the baseline. A full millimeter, gone in six weeks of nightly brushing, visible in photos without any of it. My husband spotted around week 8, which for that man is a monitoring instrument of laboratory grade. The growth was real and it was mine and I loved it. Nobody who has not measured their own eyelashes against a piece of paper understands how much a millimeter shows.

the line in the packet that got its own paragraph

I read the warning at week 8, the same night the first bottle ran dry. Iris darkening. The insert clarified that bimatoprost can stimulate melanocytes in the iris, deepening brown pigment, and that the change is reported as likely permanent. Dr. Tran, when I called back, did not sugarcoat it. Risk with lid application is low, he said, lower than with the glaucoma drops that drip right past the eye. Low is not zero, and permanent is permanent. He left the choice entirely with me, which I respected and did not enjoy.

brown eyes are the risk group

Mine are hazel-brown, the kind that go darker in winter photos, and my mother's went fully brown somewhere in her forties. The risk group for iris darkening is people with mixed and brown pigmentation to begin with. I sat with that for a week, googled photos of the documented cases at 1 a.m. twice, and read the same sentence in the insert maybe fifteen times. A cosmetic I chose for a cosmetic reason carried a permanent-color risk to the one part of my face I had never once wanted to change.

week 12, when coworkers started asking

By week 12 I had switched fully to the $28 serum, and two coworkers asked about my lashes in the same week, one of them across a conference table with the screen still on. That was the peak of the whole thing. The card that Tuesday showed 8 millimeters, and the growth had continued on the cheap bottle at approximately the same pace as the expensive one, which is a finding worth more than the $97 a bottle it saved me.

the drawer with both bottles

The math, written on the drawer side of a receipt: the prescription cost $125 per eight weeks, about $15.60 a week, forever, cuz the growth reverses when you stop. The peptide serum ran $28 per eight weeks, about $3.50 a week, also forever. An ongoing year of lashes would have cost $815 on the prescription or $182 on the serum. Both figures assume nothin' goes wrong. One of the things that can go wrong is printed in its own paragraph, and it does not reverse.

the card is still on the mirror

Six days after I stopped, the card is still taped up and the lashes are holding near the 8.5 mark, because follicles take weeks to cycle back down. They will shorten. I know the schedule, and I have decided to watch it happen without flinching at the drawer. The card stays up til the numbers settle, then the two bottles get binned. Two cards, two bottles, sixteen weeks, and one warning I could not unhear. That is the whole experiment.